Unum Therapeutics Announces Data Presentation at the Upcoming Society for Immunotherapy of Cancer (SITC) Meeting October 2, 2019
TraceLink Announces New Digital Network Platform to Further Transform the Global Pharmaceutical Supply Chain October 2, 2019
Tempest Therapeutics Announces Multiple Presentations at Upcoming Sitc 34th Annual Meeting October 2, 2019
Checkmate Pharmaceuticals Announces Dosing of First Patient in a Phase 1b/2 Study in Squamous Cell Carcinoma of the Head and Neck with Lead Investigational Candidate CMP-001 October 1, 2019
Oxford Nanopore enters into a non-exclusive agreement with Caribou Biosciences for CRISPR-Cas9 enrichment for nanopore sequencing September 30, 2019
Menlo Therapeutics Announces Completion of Enrollment of 233 Patients in Phase 2 Trial of Serlopitant in Patients with Chronic Pruritus of Unknown Origin September 30, 2019
Ultragenyx and Kyowa Kirin Announce U.S. FDA Approves Label Update for Crysvita® (burosumab) for the Treatment of X-Linked Hypophosphatemia (XLH) September 30, 2019
Orchard Therapeutics Announces Presentation of New Clinical Data for OTL-200 for Metachromatic Leukodystrophy at Upcoming European Society of Gene & Cell Therapy Annual Congress September 30, 2019